Table 5 Chemotherapy regimens prescribed to the ovarian cancer patients.
Chemotherapy | N (%) |
|---|---|
Neoadjuvant | |
Platinum | 1(10.0) |
Platinum + Paclitaxel | 7(70.0) |
Platinum + Cyclophosphamide | 1(10.0) |
No information | 1(10.0) |
Adjuvant | |
Platinum | 10(14.7) |
Paclitaxel | 3(4.4) |
Cyclophosphamide | 1(1.4) |
Platinum + Paclitaxel | 32(47.1) |
Platinum + Cyclophosphamide | 14(20.6) |
Doxorubicin | 1(1.5) |
No information | 7(10.3) |
Post-Relapse | |
Platinum | 4(17.3) |
Paclitaxel | 2(8.7) |
Gemcitabine | 5(21.7) |
Topotecam | 1(4.4) |
Etoposide | 1(4.4) |
Platinum + Paclitaxel | 9(39.1) |
No information | 1(4.4) |